Smith & Nephew plc (SN.L)
| Previous close | 1,062.50 |
| Open | 1,060.50 |
| Bid | 1,085.00 x 0 |
| Ask | 1,090.00 x 0 |
| Day's range | 1,054.00 - 1,092.50 |
| 52-week range | 887.00 - 1,215.50 |
| Volume | |
| Avg. volume | 2,739,734 |
| Market cap | 9.496B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 47.35 |
| EPS (TTM) | 0.23 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | 0.30 (2.86%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | 12.78 |
Fool.co.ukCould investing £20,000 in a Stocks and Shares ISA make me a millionaire?
Ben McPoland takes a look at how many years it might take to grow a £20k Stocks and Shares ISA portfolio to a million pounds. The post Could investing £20,000 in a Stocks and Shares ISA make me a millionaire? appeared first on The Motley Fool UK.
Globe NewswireBest-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System from the United States Food and Drug Administration. The system is designed to address the evolving demands of primary hip surgery including the increased adoption of anterior approach procedures and the expanding role of Ambu
GlobeNewswireSmith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in orthopaedic surgery. The disparity of women in the field of orthopaedic surgery compared to men is staggering. According to multiple studies, only 15% of all orthopaedic residents were women and just 7.4% were practic
